However, while results of two parallel phase 1/2 studies (NCT02690545 and NCT02917083) evaluating efficacy of CAR30 T-cells were recently reported in the cohort of patients with Hodgkin lymphoma, results of the cohort of CD30+ NHL were not published so far [156]. This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.